Shikhar Agarwal, MD
Cardiovascular Disease · Danville, PANPI 1326212101
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Edwards Lifesciences at 46.5% of the total. Reporting peaked in 2021 at $20,941 and has fallen 97.1% since, to $609 in 2025. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $392.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$25K
- Abbott$22K
- Medtronic$5K
- Ancora Heart, Inc.$1K
- Angiodynamics, Inc.$350
- Argenx US, Inc.$93
- plus $28 from 1 others
Across 71 payments — averaging $2338.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$118K
- Abbott$48K
What the payments were for
- Consulting fees$9,25017%
- Speaking & faculty fees$22,55043%
- Travel & lodging$17,67733%
- Food & beverage$3,4887%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 75 | $24,635 |
| Abbott | 41 | $21,932 |
| Medtronic(2 entities) | 12 | $4,685 |
| Ancora Heart, Inc. | 4 | $1,243 |
| Angiodynamics, Inc. | 1 | $350 |
| Argenx US, Inc. | 1 | $93 |
| Cardiac Dimensions, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$21,850
- MitraClip System$8,371
- MitraClip$7,493
- COREVALVE EVOLUT R$4,419
- Mitra Clip system$3,250
- AccuCinch$1,207
- TRICLIP$407
- AngioVac$350
- PASCAL$259
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$143
- SAPIEN 3 Ultra RESILIA$117
How this compares
$52,965 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $22,557 |
| Atorvastatin Calcium | 17 | $428 |
| Rosuvastatin Calcium | 16 | $348 |
| ClopidogrelClopidogrel Bisulfate | 17 | $211 |
| Furosemide | 30 | $199 |
| Ezetimibe | 11 | $119 |
| Amlodipine Besylate | 15 | $44 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Danville
- Dominik BeerDanville$87K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.